Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies (Q40178073)

18 September 2017

Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies (English)

1 reference

18 September 2017

0 references

1 reference

4

Klaus Uberla

1 reference

18 September 2017

3

Hans Wilhelm Doerr

1 reference

18 September 2017

2

Jindrich Cinatl

1 reference

18 September 2017

Seraphin Kuate

1

1 reference

PubMed ID

17258782

18 September 2017

language of work or name

English

0 references

publication date

26 January 2007

1 reference

18 September 2017

1 reference

18 September 2017

362

1 reference

18 September 2017

1

1 reference

18 September 2017

26-37

1 reference

Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Tumor-derived exosomes: a new source of tumor rejection antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Development of nonhuman adenoviruses as vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Severe acute respiratory syndrome (SARS) and healthcare workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Severe acute respiratory syndrome: patients were epidemiologically linked.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

The potential of exosomes in immunotherapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Induction of heat shock proteins in B-cell exosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

A sorting signal for the basolateral delivery of the vesicular stomatitis virus (VSV) G protein lies in its luminal domain: analysis of the targeting of VSV G-influenza hemagglutinin chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Severe acute respiratory syndrome: identification of the etiological agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Tetraspanin Proteins Mediate Cellular Penetration, Invasion, and Fusion Events and Define a Novel Type of Membrane Microdomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

An outbreak of severe acute respiratory syndrome among hospital workers in a community hospital in Hong Kong.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Cellular entry of the SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

The Genome sequence of the SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Polarized expression of a chimeric protein in which the transmembrane and cytoplasmic domains of the influenza virus hemagglutinin have been replaced by those of the vesicular stomatitis virus G protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Dendritic cell-derived exosomes as cell-free peptide-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

Development of a self-inactivating lentivirus vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.12.011

7 January 2021

inferred from DOI database lookup

Cancer immunotherapy using dendritic cell-derived exosomes

1 reference

12 December 2020

Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus.

1 reference

12 December 2020

Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy

1 reference

12 December 2020

Exosomes in cancer immunotherapy: preclinical data

1 reference

12 December 2020

A retention signal necessary and sufficient for Golgi localization maps to the cytoplasmic tail of a Bunyaviridae (Uukuniemi virus) membrane glycoprotein

1 reference

12 December 2020

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.

1 reference

12 December 2020

Exosomes for immunotherapy of cancer.

1 reference

12 December 2020

The transmembrane domain of vesicular stomatitis virus glycoprotein suffices to anchor HIV-1 envelope gp120 expressed by a recombinant vaccinia virus.

1 reference

12 December 2020

10.1016/J.VIROL.2006.12.011

Identifiers

DOI

1 reference

18 September 2017

0 references

1 reference

PubMed ID

17258782